US - A new Salmonella vaccine will offer poultry producers a unique opportunity to strengthen their existing Salmonella prevention programs.
Cevac Salmune TEK®, produced by Ceva Animal Health, is an inactivated polyvalent vaccine that offers protection against three of the most common strains of Salmonella.
"With the continued focus from government and consumers alike on food safety, this new vaccine will contribute significantly to Salmonella prevention programs," said Mr Gary Baxter, Vice President of Sales and Marketing for Ceva.
The first vaccine of its kind, Cevac Salmune TEK:
- Protects against three of the most common Salmonella serotypes in poultry production -Salmonella Typhimuirum, Salmonella Enteritidis, and Salmonella Kentucky
- Can be applied both subcutaneously and intramuscularly, giving more flexibility on the application process.
- Contains ImuvantTM, a dual-adjuvant technology created by combining water in oil in water (WOW) and aluminum hydroxide.
Imuvant enables administration either subcutaneously or intramuscularly without compromising the efficacy or duration of immunity.
The aluminum hydroxide provides a quick, humoral immune response, while the WOW provides for a longer duration slow release of antigen, sustaining the immune response.
"The first dose of Cevac Salmune TEK is administered at 14 weeks of age; the second dose is given four weeks later. The second dose acts as a booster, enhancing the immune response and subsequent protection," said Mr Rick van Oort, Director of Marketing and Services.
"When a food safety issue arises, it can devastate the company involved and erode consumer confidence.
"That's why it's vital that poultry producers do all they can to prevent the spread of salmonella," said Mr Baxter.
"This off-the-shelf option decreases Salmonella prevalence in one easy to apply vaccine. By incorporating Ceva Salmune TEK into the market, Ceva continues its focus on assisting poultry producers to reduce the spread of disease from animals to humans."